Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42,427 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reduced-dose radiotherapy for Epstein-Barr virus DNA selected staged III nasopharyngeal carcinoma: A single-arm, phase 2 trial.
Guo SS, Yang JH, Sun XS, Liu LZ, Yang ZC, Liu LT, Liu SL, Li XY, Lv XF, Luo DH, Li JB, Liu Q, Wang P, Guo L, Mo HY, Sun R, Yang Q, Liang YJ, Jia GD, Zhao C, Chen QY, Tang LQ, Mai HQ. Guo SS, et al. Among authors: liu lt, liu sl, liu q, liu lz. Eur J Cancer. 2023 Nov;194:113336. doi: 10.1016/j.ejca.2023.113336. Epub 2023 Sep 9. Eur J Cancer. 2023. PMID: 37801967 Clinical Trial.
Phase I dose-escalation study of nab-paclitaxel combined with cisplatin and capecitabin as induction chemotherapy followed by concurrent chemoradiotherapy in patients with nasopharyngeal carcinoma.
Yu-Chen, Luo MJ, Liu RP, Jin J, Deng SW, Tang LQ, Li XY, Liu LT, Luo DH, Sun R, Liu SL, Li JB, Liu Q, Wang P, Chen QY, Mai HQ, Guo SS. Yu-Chen, et al. Among authors: liu lt, liu sl, liu q, liu rp. Radiother Oncol. 2024 Feb;191:110051. doi: 10.1016/j.radonc.2023.110051. Epub 2023 Dec 21. Radiother Oncol. 2024. PMID: 38135184 Clinical Trial.
8-OHdG mediates the association of co-exposure to fifty-five typical endocrine-disrupting chemicals with renal function: a cross-section investigation in Southern Chinese adults.
Chen Q, Deng Q, Liao Q, Liu Y, Zhang Z, Wu D, Lv Y, Qin J, Liu Q, Li S, Long Z, Xing X, Wang Q, Zeng X, Dong G, Hou M, Xiao Y. Chen Q, et al. Among authors: liu y, liu q. Environ Sci Pollut Res Int. 2024 May;31(21):30779-30792. doi: 10.1007/s11356-024-33266-1. Epub 2024 Apr 13. Environ Sci Pollut Res Int. 2024. PMID: 38613763
The roles of 5-HT in orofacial pain.
Zou Z, Fan W, Liu H, Liu Q, He H, Huang F. Zou Z, et al. Among authors: liu h, liu q. Oral Dis. 2024 Apr 15. doi: 10.1111/odi.14960. Online ahead of print. Oral Dis. 2024. PMID: 38622872 Review.
Hyperfractionation compared with standard fractionation in intensity-modulated radiotherapy for patients with locally advanced recurrent nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial.
You R, Liu YP, Xie YL, Lin C, Duan CY, Chen DP, Pan Y, Qi B, Zou X, Guo L, Cao JY, Zhang YN, Wang ZQ, Liu YL, Ouyang YF, Wen K, Yang Q, Xie RQ, Li HF, Duan XT, Ding X, Peng L, Chen SY, Liang JL, Feng ZK, Xia TL, Xie RL, Jiang R, Gu CM, Liu RZ, Sun R, Yang X, Liu LZ, Ling L, Liu Q, Ng WT, Hua YJ, Huang PY, Chen MY. You R, et al. Among authors: liu yl, liu yp, liu rz, liu q, liu lz. Lancet. 2023 Mar 18;401(10380):917-927. doi: 10.1016/S0140-6736(23)00269-6. Epub 2023 Feb 23. Lancet. 2023. PMID: 36842439 Clinical Trial.
42,427 results
You have reached the last available page of results. Please see the User Guide for more information.